GRAIL, Inc. - Common Stock (GRAL)
30.28
-1.23 (-3.90%)
GRAIL, Inc. is a biotechnology company focused on the early detection of cancer through innovative blood tests
The company is dedicated to advancing its proprietary multi-cancer early detection technology, which aims to identify various types of cancer in their earliest, most treatable stages. By utilizing advanced genomic science and machine learning techniques, GRAIL seeks to improve patient outcomes and transform the landscape of cancer diagnostics, ultimately contributing to earlier interventions and better survival rates.
Frequently Asked Questions
Is GRAIL, Inc. - Common Stock publicly traded?
Yes, GRAIL, Inc. - Common Stock is publicly traded.
What exchange does GRAIL, Inc. - Common Stock trade on?
GRAIL, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GRAIL, Inc. - Common Stock?
The ticker symbol for GRAIL, Inc. - Common Stock is GRAL on the Nasdaq Stock Market
What is the current price of GRAIL, Inc. - Common Stock?
The current price of GRAIL, Inc. - Common Stock is 30.28
When was GRAIL, Inc. - Common Stock last traded?
The last trade of GRAIL, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025